Earnings Call · Q3 FY2023·2023-11-02

Q3 23EPS -86.07%·Rev n/aQ2 23EPS -9.77%·Rev n/aQ1 23EPS +12.41%·Rev n/aQ4 22EPS +48.60%·Rev n/a⚠ consensus missing

Cellectar Biosciences, Inc. CLRB

Monique Kosse — Investor Relations or Communications (moderator for the call)

James Caruso — President and CEO

Chad Kolean — Chief Financial Officer

Shane Lea — Commercial or Business Development Executive (responsible for commercial planning and launch activities)

Andrei Shustov — Medical or Clinical Executive (likely Chief Medical Officer or similar) based on clinical updates and medical expertise

+0.8%1d on move date−1.1% vs SPY3d+4.6%5d−12.6%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CLRB calls or request research access.

More CLRB calls Browse calls Request research access